Multifocal motor neuropathy is not associated with altered innate immune responses to endotoxin

J Neurol Sci. 2023 Aug 15:451:120692. doi: 10.1016/j.jns.2023.120692. Epub 2023 Jun 1.

Abstract

Objective: Antibody- and complement-mediated peripheral nerve inflammation are central in the pathogenesis of MMN. Here, we studied innate immune responses to endotoxin in patients with MMN and controls to further our understanding of MMN risk factors and disease modifiers.

Methods: We stimulated whole blood of 52 patients with MMN and 24 controls with endotoxin and collected plasma. With a multiplex assay, we determined levels of the immunoregulating proteins IL-1RA, IL-1β, IL-6, IL-10, IL-21, TNF-α, IL-8 and CD40L in unstimulated and LPS-stimulated plasma. We compared baseline and stimulated protein levels between patients and controls and correlated concentrations to clinical parameters.

Results: Protein level changes after stimulation were comparable between groups (p > 0.05). IL-1RA, IL-1β, IL-6 and IL-21 baseline concentrations showed a positive correlation with monthly IVIg dosage (all corrected p-values < 0.016). Patients with anti-GM1 IgM antibodies showed a more pronounced IL-21 increase after stimulation (p 0.048).

Conclusions: Altered endotoxin-induced innate immune responses are unlikely to be a susceptibility factor for MMN.

Keywords: Endotoxin; Immunology; Inflammatory neuropathy; Innate immunity; Multifocal motor neuropathy.

MeSH terms

  • Antibodies
  • Endotoxins* / toxicity
  • Humans
  • Immunity, Innate
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-6
  • Polyneuropathies* / chemically induced

Substances

  • Endotoxins
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-6
  • Antibodies